SVB Leerink

We provide healthcare and technology-focused companies and investors a broad suite of financial solutions comprising of M&A advisory, equity and debt capital markets, proprietary research, and comprehensive sales and trading capabilities

We are a market leader partnering with innovative healthcare and technology companies throughout their financial lifecycle Learn More We leverage our long-term relationships, highly-regarded sector knowledge and transaction experience to deliver outcomes for our clients Learn More Delivering unique insights on equity-related products for institutional clients Learn More Industry recognized equity research analysts offer a differentiated perspective on the healthcare and technology sub-sectors driving innovation Learn More Corporate clients and financial sponsors require expertise in structuring, underwriting, and syndicating a broad array of debt financing solutions Learn more Exclusive access to Key Opinion Leaders (KOLs) and healthcare professionals is an essential service for our Equity Research and Investment Banking teams and healthcare clients as they evaluate opportunities Learn More

UP TO CHF 200 MILLION

$260 MILLION + UP TO $1.8B IN MILESTONE PAYMENTS

Digital Health’s Dot Com Moment – Peril and Promise

Biopharma / SITC 2022: IO Development and Regulatory Discussions

Healthcare Technology & Distribution / 2022 Digital Health: Innovators & Disruptors Conference Takeaways

to achieve your strategic, capital markets, and investment objectives

Stay ahead of what’s next. Sign Up Now!

• Notice to California Residents "*" indicates required fields